Date when an entity was incorporated

No definition available.

Name:	dei_EntityIncorporationDateOfIncorporation
Namespace Prefix:	dei_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

An offering price is the per-share value at which publicly issued securities are made available for purchase by the investment bank underwriting the issue.

+ References

No definition available.

+ Details

Name:	tffp_AaggregateOfferingPrice
Namespace Prefix:	tffp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of net proceeds of initial public offering.

+ References

No definition available.

+ Details

Name:	tffp_NetProceedsOfInitialPublicOffering
Namespace Prefix:	tffp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- References

No definition available.

+ Details

Name:	tffp_OrganizationAndDescriptionOfBusinessLineItems
Namespace Prefix:	tffp_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Purchase of warrat percentage.

+ References

No definition available.

+ Details

Name:	tffp_PurchaseOfWarratPercentage
Namespace Prefix:	tffp_
Data Type:	dtr:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Underwriters option period from the date of initial public offering.

+ References

No definition available.

+ Details

Name:	tffp_UnderwritersOptionPeriodFromTheDateOfInitialPublicOffering
Namespace Prefix:	tffp_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_CommonStockSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow associated with the amount received from entity's first offering of stock to the public.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 14
-Subparagraph (a)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-14

+ Details

Name:	us-gaap_ProceedsFromIssuanceInitialPublicOffering
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of shares of stock issued attributable to transactions classified as other.

+ References

No definition available.

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesOther
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=tffp_ATMOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=tffp_November2022PublicOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=tffp_August2023PublicOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ConsolidatedEntitiesAxis=tffp_TFFPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=tffp_UnderwriterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tffp_JefferiesLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Organization and Description of Business (Details) - USD ($)					1 Months Ended	3 Months Ended	12 Months Ended
	Aug. 17, 2023	Nov. 30, 2022	Jul. 10, 2022	Jun. 10, 2022	Nov. 30, 2022	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Organization and Description of Business [Line Items]
Gross proceeds							$ 5,064,722
Underwriters Option Period from the Date of Initial Public Offering					45 days
Common stock issued							2,370,000	1,447,722
ATM Offering [Member]
Organization and Description of Business [Line Items]
Aggregate offering price			$ 35,000,000
Sale of common shares						4,160
Sale of stock price per share						$ 149
Net proceeds				$ 400,000		$ 400,000
November 2022 Public Offering [Member]
Organization and Description of Business [Line Items]
Sale of common shares					371,304
Sale of stock price per share		$ 28.75			$ 28.75
Net proceeds					$ 11,200,000
Shares of warrant to purchase		185,652			185,652
Gross proceeds					$ 10.7
Percentage of common stock		15.00%			15.00%
August 2023 Public Offering [Member]
Organization and Description of Business [Line Items]
Sale of common shares	915,216
Sale of stock price per share	$ 6,250,000
Net proceeds	$ 5,100,000
Gross proceeds	$ 5,700,000
Common stock issued	119,376
Common Stock [Member] \| ATM Offering [Member]
Organization and Description of Business [Line Items]
Net proceeds				$ 60,000
Warrant [Member] \| November 2022 Public Offering [Member]
Organization and Description of Business [Line Items]
Shares of warrant to purchase		27,848			27,848
Gross proceeds		$ 1,600,000			$ 1,600,000
TFF Pharmaceuticals, Inc. [Member]
Organization and Description of Business [Line Items]
Incorporation date							Jan. 24, 2018
Underwriter [Member] \| November 2022 Public Offering [Member]
Organization and Description of Business [Line Items]
Additional shares of common stock		55,696			55,696
Jefferies LLC [Member] \| ATM Offering [Member]
Organization and Description of Business [Line Items]
Sale of common shares						4,160
Sale of stock price per share				$ 149
Jefferies LLC [Member] \| Common Stock [Member] \| ATM Offering [Member]
Organization and Description of Business [Line Items]
Sale of common shares							7,062
Sale of stock price per share							$ 8.8